447
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Interactions between Chemotherapy, Endocrine Therapy and Radiation

, , , &
Pages 635-638 | Published online: 08 Jul 2009

  • Zackrisson B, Kjellén E, Glimelius B, Carlsson J, Littbrand B, Turesson I. Sensitising and protective substances in radiation therapy and predictive assays. Acta Oncol 2002; 41: 615-22.
  • Mason KA, Komaki R, Cox JD, et al. Biology-based combined-modality radiotherapy: workshop report. Int J Radiat Oncol Biol Phys 2001; 50: 1079-89.
  • von der Maase H. Combined radiotherapy and chemotherapy. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology. Oxford: Oxford University Press, 2001: 489-509.
  • Pignon JP, Bourkis J, Domenge C, et al. Chemotherapy added to locoregional treatment of head and neck squamous carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949-55.
  • Sternberg CN, Parmar MKB. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer. J CHn Oncol 2001; 19: 21-6.
  • Rose PG, Bundy BN. Chemoradiation for locally advanced cervical cancer: does it help? J Clin Oncol 2002; 20: 891-3.
  • Schilsky RL. Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers. Sem Oncol 1992; 19 (Suppl 11): 2-7.
  • Smalley SR, Kimler BF, Evans RG. S-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 1991; 20: 207-11.
  • Formend SC, Danenberg PV. Paclitaxel-induced radiosensitization: myth or reality? Adv Oncol 1999; 5: 125-9.
  • von der Maase H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour. Radiother Oncol 1986; 7: 47-68.
  • Medical Research Council Prostate Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol 1997; 79: 235-46.
  • Granfors T, Modig H, Dam her J-E, et al. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized trial. J Urol 1998; 159: 2030-4.
  • Pollack A, Salem N, Ashoori F, et al. Lack of prostate cancer radiosensitization by androgen deprivation. Int J Radiat Oncol Biol Phys 2001; 51: 1002-7.
  • Bentzen SM, Skoczylas JZ, Overgaard M, et al. Radiotherapyrelated lung flbrosis enhanced by tamoxifen. J Natl Cancer Inst 1996; 88: 918-22.
  • Sertoli MR, Pronzato P, Venturini M, et al. A randomized study of concurrent versus sequential adjuvant chemotherapy and tamoxifen in stage II breast cancer. Proc Am Soc Clin Oncol 2002; 21: Abstr 182.
  • Harari PM, Huang S-M. Augmentation of radiation therapy after growth factor signaling blockade. Proc Am Soc Clin Oncol, Educational Book 2001; 42-6.
  • Milas L, Mason K, Hunter N, et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res 2000; 6: 701-8.
  • Nasu S, Ang K, Fan Z, et al. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys 2001; 51: 474-7.
  • Travis L. Therapy-associated secondary solid cancer. Acta Oncol 2002; 41: 323-33.
  • Glimelius B. Chemoradiotherapy for rectal cancer-is there an optimal combination? Ann Oncol 2001; 12: 1039-45.
  • Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002; 41: 118-23.
  • Van Houtte P. The role of radiotherapy and the value of combined treatment in lung cancer. Eur J Cancer 2001; 37 (Suppl 7): S91-8.
  • Coleman CN. Radiation oncology-Linking technology and biology in the treatment of cancer. Acta Oncol 2002; 41: 6-13.
  • Turesson I, Stenerlöw B, Carlsson J, et al. and the Swedish Cancer Society Investigation Group. Radiobiological response to radiation. Acta Oncol 2003; 42: (in press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.